Synthesis and evaluation of ursolic acid-based 1,2,4-triazolo[1,5-a]pyrimidines derivatives as anti-inflammatory agents. 2022

Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
Jilin Medical University, Jilin, 132013, Jilin Province, People's Republic of China. tianyizhang@126.com.

Here, two series of novel ursolic acid-based 1,2,4-triazolo[1,5-a]pyrimidines derivatives were synthesized and screened for their anti-inflammatory activity by evaluating their inhibition effect of using LPS-induced inflammatory response in RAW 264.7 macrophages in vitro; the effects of different concentrations of the compounds on the secretion of nitric oxide (NO) and inflammatory cytokines including TNF-α and IL-6 were evaluated. Their toxicity was also assessed in vitro. Results showed that the most prominent compound 3 could significantly decrease production of the above inflammatory factors. Docking study was performed for the representative compounds 3, UA, and Celecoxib to explain their interaction with cyclooxygenase-2 (COX-2) receptor active site. In vitro enzyme study implied that compound 3 exerted its anti-inflammatory activity through COX-2 inhibition.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D000097245 Ursolic Acid A pentacyclic triterpene that co-occurs with its isomer OLEANOLIC ACID in several plant species, and occurs in large amounts in FRUITS (such as CRANBERRIES; PEARS; PLUMS; and OLIVES), MEDICINAL HERBS, and other plants. (+)-Ursolic Acid,(3 beta)-3-Hydroxyurs-12-en-28-oic Acid,3-Epi-Ursolic Acid,3-Epiursolic Acid,3alpha-Ursolic Acid,3beta-Ursolic Acid,Olean-12-en-28-oic Acid, 3-Hydroxy-, Sodium Salt (1:1), (3beta)-,Sodium Oleanolate,Ursolic Acid Monosodium Salt,Ursolic Acid Sodium Salt,Ursolic Acid, (3beta)-Isomer, 2-(14)C-Labeled,Ursolic Acid, (3beta)-Isomer, Monopotassium Salt,Merotaine,3 Epi Ursolic Acid,3 Epiursolic Acid,3alpha Ursolic Acid,3beta Ursolic Acid,Oleanolate, Sodium
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D051546 Cyclooxygenase 2 An inducibly-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes and INFLAMMATION. It is the target of COX2 INHIBITORS. COX-2 Prostaglandin Synthase,Cyclo-Oxygenase II,Cyclooxygenase-2,PGHS-2,PTGS2,Prostaglandin H Synthase-2,COX 2 Prostaglandin Synthase,Cyclo Oxygenase II,Prostaglandin H Synthase 2,Prostaglandin Synthase, COX-2,Synthase, COX-2 Prostaglandin
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
February 2021, European journal of medicinal chemistry,
Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
May 2015, Journal of medicinal chemistry,
Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
May 2007, Molecules (Basel, Switzerland),
Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
July 2018, Bioorganic & medicinal chemistry letters,
Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
April 2013, European journal of medicinal chemistry,
Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
February 2009, Archiv der Pharmazie,
Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
August 2009, Chemistry & biodiversity,
Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
May 2012, Steroids,
Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
May 1999, Bollettino chimico farmaceutico,
Tian-Yi Zhang, and Chun-Shi Li, and Ping Li, and Xue-Qian Bai, and Shu-Ying Guo, and Ying Jin, and Sheng-Jun Piao
January 2009, Drug metabolism letters,
Copied contents to your clipboard!